Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Bayer Strengthens Gene Therapy Portfolio With Lipid Nanoparticle Technology From Acuitas Therapeutics
Bayer AG is joining forces with Acuitas Therapeutics, a biotechnology company specializing in the development […]
BioCentriq® and Kytopen® Expand Partnership to Expedite Impact of Transformative Gene-Editing Technology on Cell Therapy Manufacturing
BioCentriq, a strategic CDMO (contract development and manufacturing organization) specializing in cell therapy announced today […]
NYU Langone Health and Deerfield Management Launch Amethyst Innovations with Up To $130 Million to Accelerate Commercialization of Biomedical Discoveries
NYU Langone Health and Deerfield Management Company, a healthcare investment firm, today announced the launch […]
RoslinCT and Lykan Bioscience Announce Integration to Establish Global Advanced Cell and Gene Therapy CDMO Service Offerings
RoslinCT and Lykan Bioscience, two leading Contract Development and Manufacturing Organizations (CDMOs) in the Cell […]
The University of Oxford and Selvita Collaborate to Advance Potential Therapeutics for Parkinson's Disease
The University of Oxford and Selvita, one of the largest contract research organizations in Europe, […]
VaxEquity and CPI Announces Innovate UK Grant to Accelerate Next Generation RNA Vaccines and Therapeutics
VaxEquity, developing transformative RNA vaccines and therapeutics based on its next-generation self-amplifying RNA (saRNA) platform, […]
Providence Therapeutics Announces Partnership with University Health Network (UHN) for mRNA Therapeutic Discovery and Development
Providence Therapeutics, a biopharmaceutical company developing messenger RNA (mRNA) vaccines and therapeutics, today announced its […]
Landmark Bio Partners With InnDura Therapeutics to Advance Immune Cell Therapy Research
Landmark Bio, a collective endeavor bringing together leaders in industry, academia, and research hospitals to […]
Rentschler Biopharma Joins Forces with Ikarovec to Accelerate Novel Gene Therapies for Treatment of Ophthalmic Disease
Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, including […]
invoX Pharma Increases Investment in pHion Therapeutics to Further Develop Next Generation of mRNA Vaccines
invoX Pharma, a U.K.-based wholly-owned subsidiary of Sino Biopharmaceutical with an advancing pipeline of innovative […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more